---
title: >-
  Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and
  Post-fracture Treatment Among Commercially Insured Postmenopausal Women in the
  United States.
description: >-
  Explore this publication on real-world evidence: Current Trends in the Risk of
  Subsequent Fracture After Initial Fracture, and Post-fracture Treatment Among…
date: '2023-01-01'
category: Publications
tags:
  - Acr Convergence
  - Care
  - Osteoporosis/Bone
  - Health System Partner
  - Oral Presentation
  - Pharma Partner
  - R&D
  - Methods/Pharmacoepi
canonical_url: >-
  https://www.pedestalhealth.com/resources/publications/acr-convergence/current-trends-in-the-risk-of-subsequent-fracture-after/
source: Pedestal Health
license: © 2026 Pedestal Health. All rights reserved.
slug: current-trends-in-the-risk-of-subsequent-fracture-after
id: 3ovOAIYkQhfAHEnz23CMQB
contentType: article
---

## Challenge

Post-fracture treatment rates among commercially insured post-menopausal women in the US have been declining, but contemporary trends in subsequent fracture risk and post-fracture treatment utilization among younger commercially insured women had not been characterized.

## Solution

Target RWE and Amgen researchers analyzed a large commercial insurance claims database to describe yearly fracture incidence rates, subsequent fracture risk, and post-fracture pharmacologic treatment patterns among post-menopausal women from 2012 to 2021.

## Impact

Demonstrating persistently low post-fracture treatment rates in commercially insured women provides Amgen with compelling real-world evidence of a treatment gap supporting the commercial and clinical case for osteoporosis therapy.

### [Kathleen Hurwitz](/people/kathleen-hurwitz/)